Literature DB >> 2413945

The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats.

B Hughes, J R Parratt.   

Abstract

The administration of endotoxin derived from Escherichia coli to anaesthetized cats resulted, within the first 5 min, in an initial increase in right atrial pressure and a reduction in systemic arterial blood pressure. Over the next 2 h shock was characterized by a reduced cardiac output, tachycardia, reduced arterial pH and an increased level of lactate. The survival rate at the end of the 8 h experimental period was only 10%. The protease inhibitor aprotinin (Trasylol), given as a continuous intravenous infusion 1000 kallikrein inhibitor units (k.i.u.) kg-1h-1 together with a bolus of 40,000 k.i.u. kg-1, significantly inhibited the severity and incidence of the initial endotoxin response (increase in right atrial pressure and systemic hypotension), perhaps suggesting the direct or indirect involvement of kinins. Aprotinin did not reduce the delayed effects of endotoxin (sustained reduction in cardiac output, lacticacidosis), nor did it improve survival at 8 h. Indeed, there was some evidence that aprotinin exaggerated the delayed effects of endotoxin in this model.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413945      PMCID: PMC1916700          DOI: 10.1111/j.1476-5381.1985.tb08909.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  CHEMICAL MEDIATORS IN CLINICAL SEPTIC SHOCK.

Authors:  E E KOBOLD; R LUCAS; A P THAL
Journal:  Surg Forum       Date:  1963

2.  The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Experimental studies on the effect of prophylactic proteinase inhibitor therapy on endotoxin shock.

Authors:  S Sumida
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

4.  Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

5.  Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys.

Authors:  A S Nies; R P Forsyth; H E Williams; K L Melmon
Journal:  Circ Res       Date:  1968-02       Impact factor: 17.367

6.  Endotoxin-induced kinin production in man.

Authors:  H R Kimball; M L Melmon; S M Wolff
Journal:  Proc Soc Exp Biol Med       Date:  1972-03

7.  Proteinases and proteinase inhibitors in experimental shock states.

Authors:  N Back; H Wilkens; R Steger
Journal:  Ann N Y Acad Sci       Date:  1968-06-28       Impact factor: 5.691

8.  Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.

Authors:  B Hughes; B R Madan; J R Parratt
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

9.  The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions.

Authors:  G L Haberland
Journal:  Klin Wochenschr       Date:  1978-04-01

10.  Prostacyclin release and the modulation of some vasoactive hormones.

Authors:  K M Mullane; S Moncada
Journal:  Prostaglandins       Date:  1980-07
View more
  2 in total

1.  Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal.

Authors:  F Brunet; J P Mira; M Belghith; J J Lanore; S Schlumberger; P Toulon; J F Dhainaut
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Feline endotoxin shock: effects on tissue histamine and histidine decarboxylase activity.

Authors:  J R Parratt; S Saleh; N G Waton
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.